23rd November 2022 | Pharma Updates

Latest pharmaceutical industry news and updates

*Refresh the page if the below document does not appear.

Anti-trust lawsuit filed against DRL and other Generic Pharma companies in the US

Dr. Reddy’s Laboratories on Tuesday mentioned that an anti-trust lawsuit has been filed against them along with some other generic pharma companies including Celgene and Bristol Myers Squibb in the US on November 18, 2022.

GSK to stop sales of its Blood Cancer drug "Blenrep" in the US

The company stated that earlier this month Blenrep failed to meet the main goal of a study designed to show it was better than an existing treatment on the market. Thus, the company decided to stop the sale of Blenrep in the US amidst the fear that regulatory approval could be removed by the US FDA.

Lumos Pharma’s LUM-201 holds potential to improve compliance in pediatric cases: GlobalData

According to GlobalData, a leading data and analytics company, with a favorable route of administration LUM-201 has the potential to improve low rates of treatment compliance in PGHD (Pediatric Growth Hormone Deficiency) cases.

CPhI & P-MEC India expo to connect with knowledge technologies and market opportunities

CPhI & P-MEC India, Informa Markets is organizing its event (15th edition) in an hybrid format from 29th November to 1st December, 2022 at the India Expo Centre, Greater Noida, Delhi – NCR.

Jazz Pharma receives USFDA nod for revised dosing schedule for Blood Cancer therapy

The drugmaker Jazz Pharmaceuticals received FDA approval for a revised dosing schedule for its Blood Cancer Therapy ‘Rylaze’ , giving medical practitioners the option of prescribing intramuscular doses of the drug on Monday, Wednesday, and Friday.

Haryana Govt launched "SAATHI" app to keep a check on drug abuse

The Haryana Government has started app-based monitoring to keep a check on the abuse of habit-forming drugs in the state. The app “SAATHI” has been launched as a pilot project in the Sonipat district.

USV to expand its pharma manufacturing facility at Baddi, Himachal Pradesh

USV Pharma is planning to expand its pharma unit capacity at HPSIDC Industrial Area, Baddi, in Himachal Pradesh’s Solan district. The ₹ 97 crore project will cover additional 3.39 acres of land and will employ around 30 additional employees.

PharmaState.academy offers easy access to training & up-skilling programs created by experts from Pharma Industry.
Start chat
1
Need Help?
PharmaState Academy
Hello, how can we help you?